News

Affluent Medical, a new French medtech player, today announces the postponement of its initial public offering (IPO) to list its shares for trading on the Euronext Growth market in Paris.

On June 7, 2018, the Autorité des marchés financiers (AMF) approved, under number 18-231, the prospectus relating to the IPO of the shares of Affluent Medical, comprising the Document de Base, filed under number I.18-045 on May 28, 2018, and a Note d'Opération (securities note) (including a summary of the prospectus).

Affluent Medical, a new French medtech player, announces today that it has filed its Document de Base with the Autorité des marchés financiers (AMF) on May 28, 2018, with registration number I. 18-045.

AFFLUENT MEDICAL hosted a Key Opinion Leader event Wednesday, May 23, 2018 on New Generation Technologies for Minimally Invasive Surgery of the Mitral Valve and Abdominal Aorta. Key opinion leaders (KOLs) present were Professor Christian Latrémouille (Georges Pompidou European Hospital) and Professor Stéphan Haulon (Université Paris Sud) who discussed novel surgical technologies for the treatm